… benefit of the use of angiotensin converting enzyme inhibitors (ACE-I) in … ACE-I in patients
with cardiovascular disease. The Task Force members for the Angiotensin Converting Enzyme …

… We included studies that directly compared ACE inhibitors, ARBs, and/or DRIs in at … ACE
inhibitors versus ARBs and three studies directly comparing DRIs to ACE inhibitor inhibitors …

… of ACE inhibitors as antihypertensive agents, compares their efficacy, tolerability, and safety
to ARBs, and highlights the contemporary issues surrounding ACE inhibitor use for HTN. …

… an ACE inhibitor (ACEI) or Angiotensin-2 receptor inhibitors (ARB) combined with a CCB
and/or diuretic as the core treatment strategy for most patients, with B-blockers used for specific …

… of hypertension are ACE inhibitors, ARBs, beta-… ), ACE inhibitors (indicated for all stages of
heart failure), ARBs (mainly used in patients who develop adverse reactions to ACE inhibitors)…

… These patients were separated into 2 categories: those on chronic ACE inhibitors and those
not on ACE inhibitors. The investigators tested hormonal responses to norepinephrine and …

… initially received 2.5 or 5.0 mg of lisinopril daily, titrated to 12.5 or 15.0 mg daily. … ACE inhibitor
were switched to 12.5 or 15.0 mg of lisinopril. At the end of 4 weeks of open-label lisinopril …

… tends to enhance an ACE inhibitor’s effect on BP. The efficacy of an ACE inhibitor is also …
the variability in ACE inhibitor responses, however, because ACE inhibitors are effective at …

… We also evaluated studies of ARBs versus other (non–ACE inhibitor) comparators and ACE
inhibitors versus other (non-ARB) comparators, which were to be considered in case too few …

… are available, including the angiotensin converting enzyme (ACE) inhibitors (ACEI). However
… This paper reports the rationale for the cardiovascular protective effects of ACE inhibitors (…